B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 6.45 NOK -11.19% Market Closed
Market Cap: 261.9m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bergenbio ASA
Total Liabilities Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Total Liabilities
kr43.2m
CAGR 3-Years
-15%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Total Liabilities
kr247.3m
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
9%
L
Lytix Biopharma AS
OSE:LYTIX
Total Liabilities
kr12.6m
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Total Liabilities
kr21.5m
CAGR 3-Years
-12%
CAGR 5-Years
-5%
CAGR 10-Years
10%
N
Nykode Therapeutics ASA
OSE:NYKD
Total Liabilities
$27.8m
CAGR 3-Years
-14%
CAGR 5-Years
80%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Total Liabilities
kr60.1m
CAGR 3-Years
-21%
CAGR 5-Years
-13%
CAGR 10-Years
24%

See Also

What is Bergenbio ASA's Total Liabilities?
Total Liabilities
43.2m NOK

Based on the financial report for Jun 30, 2024, Bergenbio ASA's Total Liabilities amounts to 43.2m NOK.

What is Bergenbio ASA's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
5%

Over the last year, the Total Liabilities growth was -18%. The average annual Total Liabilities growth rates for Bergenbio ASA have been -15% over the past three years , 5% over the past five years .

Back to Top